Empathia AI vs OneChart (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

Two small ambient scribes serving the same North American market from different angles. Empathia is built deliberately for two jurisdictions at once, claiming compliance with the United States and Canadian regimes, which is a harder problem than it sounds because the two frameworks make different demands about where data lives and who may hold it. OneChart is a small Canadian team whose notable feature is the breadth of clinical settings it covers for its size. For a practice that operates across the border or a clinic that expects to, the dual market design is worth something concrete. For everyone else these are close enough that the decision comes down to the pilot. Neither publishes a study, an accuracy figure or a security attestation, so the diligence burden sits entirely with the buyer in both cases.

The case for Empathia AI
  • It was built for two markets at once and states compliance in both, which is the harder engineering and contracting problem rather than a marketing claim.
  • For a practice operating across the border, or a vendor selling into both, one product with both regimes addressed removes a real procurement obstacle.
  • Dual market design usually forces clearer data handling decisions than a single market product needs to make.
The case for OneChart
  • The breadth of clinical settings it reaches is unusual for its size, which suggests the note generation is genuinely general rather than tuned to one visit type.
  • A small team focused on coverage rather than adjacent products keeps the surface narrow, and a narrow surface is easier to evaluate and to govern.
  • For a clinic that wants documentation and nothing else, an unbundled product avoids paying for agents it will not switch on.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Empathia AI and OneChart are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Empathia AI OneChart
Primary category Ambient Scribes Ambient Scribes
Founded Not recorded 2024
Headquarters Not recorded Hamilton, Ontario, Canada
Website empathia.ai onechart.ai
Attribute Matrix

Side by Side

Axis
E
Empathia AI
O
OneChart
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

Empathia AI

The AI Health Index awards Empathia AI its top capability grade on AI Centrality, Model Supply Chain Disclosure and Setting and Specialty Coverage. Set against OneChart, Empathia AI grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

OneChart

The AI Health Index awards OneChart its top capability grade on AI Centrality, Commercial Transparency and Setting and Specialty Coverage. Set against Empathia AI, OneChart grades higher on Commercial Transparency. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose Empathia AI or OneChart?

On the axes where the AI Health Index separates them, Empathia AI grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence, and OneChart grades higher on Commercial Transparency. Empathia AI leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.

Where do Empathia AI and OneChart differ most?

The widest separation the AI Health Index records between Empathia AI and OneChart is on Model Supply Chain Disclosure, where Empathia AI grades A and OneChart grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.

Where do Empathia AI and OneChart grade the same?

The AI Health Index grades Empathia AI and OneChart the same on several axes, including AI Centrality, Autonomy and Oversight Model and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

What have Empathia AI and OneChart not disclosed?

At the last review, at least one of Empathia AI and OneChart published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.

Disclosure

Both are small vendors and the diligence burden sits accordingly with the buyer: neither publishes a study, controlled evaluation, accuracy benchmark or named customer deployment, and neither publishes a security attestation, retention schedule or subprocessor list. For any dual market claim, check which entity holds the data and where processing occurs, since asserting compliance with two regimes is not the same as demonstrating data residency in each. Neither publishes an accent, dialect or language performance analysis, which matters in bilingual practice.